WATERTOWN, Mass., Sept. 10, 2020 (GLOBE NEWSWIRE) — Aileron Therapeutics (NASDAQ:ALRN) today announced that Manuel Aivado, M.D., Ph.D., President and […]
-NTAP designation highlights need for novel antibiotics to fight drug-resistant infections and advance antimicrobial stewardship-CONTEPO first Qualified Infectious Disease Product […]
Characterization of novel immunotherapy approach with CPI-006 and details of COVID-19 clinical trial results submitted for publication online at medRxiv.orgPatients […]